These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25198774)

  • 1. PfalDB: an integrated drug target and chemical database for Plasmodium falciparum.
    Kumar A; Agarwal N; Pant L; Singh JP; Ghosh I; Subbarao N
    Curr Drug Targets; 2014; 15(12):1089-93. PubMed ID: 25198774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apicoplast Import Protein Tic20 A Promising Therapeutic Molecular Target for Plasmodium falciparum: An In Silico Approach for Therapeutic Intervention.
    C P K Srimath-Tirumala-Peddinti R; Kusuma SS; Nammi D; Neelapu NRR
    Infect Disord Drug Targets; 2017; 17(3):199-222. PubMed ID: 28595540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials.
    Sheridan CM; Garcia VE; Ahyong V; DeRisi JL
    Malar J; 2018 Dec; 17(1):465. PubMed ID: 30541569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.
    Mogire RM; Akala HM; Macharia RW; Juma DW; Cheruiyot AC; Andagalu B; Brown ML; El-Shemy HA; Nyanjom SG
    PLoS One; 2017; 12(10):e0186364. PubMed ID: 29088219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplasmodial drug targets: a patent review (2000 - 2013).
    Okombo J; Chibale K
    Expert Opin Ther Pat; 2016; 26(1):107-30. PubMed ID: 26566576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A database of antimalarial drug resistance.
    Sibley CH; Ringwald P
    Malar J; 2006 Jun; 5():48. PubMed ID: 16774688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast.
    Bispo NA; Culleton R; Silva LA; Cravo P
    PLoS One; 2013; 8(3):e59288. PubMed ID: 23555651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitors.
    Afolabi R; Chinedu S; Ajamma Y; Adam Y; Koenig R; Adebiyi E
    Infect Genet Evol; 2022 Jan; 97():105194. PubMed ID: 34968763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.
    Qidwai T; Priya A; Khan NA; Tripathi H; Khan F; Darokar MP; Pal A; Bawankule DU; Shukla RK; Bhakuni RS
    Curr Drug Targets; 2014 Apr; 15(4):374-409. PubMed ID: 23848395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drugs and their useful therapeutic lives: rational drug design lessons from pleiotropic action of quinolines and artemisinins.
    Muregi FW
    Curr Drug Discov Technol; 2010 Dec; 7(4):280-316. PubMed ID: 21034413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.